echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Did not do Phase III. Clinical, why should the russian new crown vaccine be listed at the speed of light?

    Did not do Phase III. Clinical, why should the russian new crown vaccine be listed at the speed of light?

    • Last Update: 2020-09-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Russian President Vladimir Putin announced at a government meeting that the first new crown vaccine has been registered in Russia and that his daughter has taken the lead in getting it, according to Russian satellite news agency on August 11.
    Russian President Vladimir Putin announced at a government meeting that the first new crown vaccine had been registered in Russia and that his daughter had taken the lead in getting it, Russian satellite news agency reported on August 11.
    Russian Health Minister Murashko said the vaccine was named Sputnik 5, noting that the new coronavirus vaccine can create long-term immunity, which lasts for two years.
    also noted that production of the vaccine is currently starting in two locations: the Russian Ministry of Health's National Research Centre for Epidemiology and Microbiology of "Gameleya" and one at Binnopharm.
    , technical regulations are being developed to scale up production.
    Although Dmitryev, president of the Russian Direct Investment Fund, said at the "Russia Today" international news agency's online conference that more than 1 billion initial applications for the vaccine had been received from more than 20 countries, the safety and effectiveness of the vaccine have also been questioned by many.
    the U.S. Clinical Trials Database (GamaleyaInstitute) and found the results: The study began on June 18, less than two months ago.
    the study was divided into two stages: 18 volunteers in the first phase, who were subjected to safety monitoring for 5 consecutive days after the drug was given, and 20 volunteers were tested according to the experimental scheme, with follow-up time of 7, 14, 28 and 42 days after the drug was given.
    information during hospital observation and follow-up throughout the study period (180 days in total). According to the information published by
    , the vaccination component 1 consists of a recombinated adenovirus vector of human adenovirus type 26, which contains the S protein gene of SARS-CoV-2, and component 2 consists of a carrier of human adenovirus type 5, which contains the S protein gene of SARS-CoV-2.
    "Satellite 5" light speed on the market, the subjects only 38 people, and did not do Phase III. Clinical, is the main reason for people to question.
    , for example, U.S. infectious disease expert Fuchs said in an interview that he was seriously skeptical of the Russian vaccine.
    "We've developed a dozen vaccines, and if we want to give people something that doesn't work, we can start (vaccinations) next week. . . I hope the Russians have confirmed that the vaccine is safe and effective, but I have serious doubts about it and there is no evidence that they did.
    " has also been pointed out that vaccines that have not been fully clinically analyzed may lead to ADE effects.
    that is, the vaccinated human immune system mistakenly believes that the virus has been blocked, it is possible to encounter a mutated virus, to assist the virus into the target cells, resulting in the body more susceptible to infection, more severe symptoms.
    Contact to August 9, Japan's National Institute of Infections announced that The japanese epidemic strain has six base mutations, although some experts pointed out that "from the first day of the emergence of the new coronavirus to the present, the virus has been mutated, the mutation does not equal to more dangerous", but from the published information, such concerns are not unreasonable.
    russia has pushed for a vaccine so aggressively, probably because of that? 1. Stabilize the population of Russia more than 100 million people, has nearly 900,000 confirmed, still maintain 5,000 to 6,000 new cases every day, the domestic form is not optimistic.
    Moremore, according to the Russian Federal Statistical Office, Russia's GDP fell by 8.5% in the second quarter, with the exception of agriculture, the growth rate of industrial value added in all sectors of the national economy declined, with the largest declines in raw materials production, retailing, passenger transport and residential services.
    addition, The Russian Minister of Education and Science, Valery Farikov, said that the Ministry hoped that the school year would begin on 1 September and that it planned to adopt the traditional model of teaching (re-education).
    (Russia's satellite news agency, April 22) In the face of an out-of-control domestic epidemic, a depressed economic environment and schools waiting to resume classes, there is a great need for good news that will boost national confidence.
    2. On the day of the Russian vaccine's launch, according to CNBC local time, Trump announced at the White House briefing that the U.S. government will order 100 million doses of the experimental new crown vaccine "mRNA-1273" from Modena.
    , Modena's new crown vaccine development is currently in the third phase of clinical trials, will test the effectiveness and safety of the vaccine in about 30,000 people.
    addition, it has been found that the vaccine was named Sputnik V- Sputnik 5, inheriting the name of Sputnik 1, the first satellite launched by the Soviet Union, with deep political implications.
    (Sputnik 1 is the product of the space enlightenment era, is a symbol of space competition during the Cold War) the new crown prevention and control is a matter of human destiny, in addition to political, social and other factors, we look forward to safe and effective vaccines to prevent the new crown to play a positive role.
    now, both China and the United States have new crown vaccines in Phase III clinical.
    For example, chen Wei's team and Consino's adenovirus vector vaccine are already in Phase III clinical trials and have been approved for military-only drugs, and inactivated vaccines from the China Bio-Wuhan Biological Products Research Institute and The National Pharmaceutical Group have entered Phase III clinical trials and are expected to be available by the end of this year or early next year.
    Despite the constant questioning of the Russian "Satellite 5" vaccine, for whatever reason, we sincerely hope that the new crown vaccine will play an active role in protecting people's lives.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.